Similar to tariffs in which Trump felt that the United States was not treated fairly when it came to be taxed on certain ...

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The financial decision is due to customer demand stemming from the reshoring of drug supply services.

In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs’ potential into ...

In the first part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

However, in order to fully unlock these massive opportunities, life science companies must embrace a new way of operating and ...

As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders ...